Aims & Scope

Endocrinology, Diabetes & Metabolism Endocrinology, Diabetes & Metabolism is a peer-reviewed, open access, interdisciplinary journal providing rapid publication across the breadth of endocrinology, diabetes and metabolism research.

The journal considers articles and reviews which focus on the clinical and scientific aspects of endocrinology, the clinical application of molecular endocrinology, diabetes care and clinical management.

It also welcomes work on new or existing diabetes therapies, including dietary, exercise and lifestyle (non-pharmacological) interventions, in any aspect of metabolic and endocrine disease, either in humans or animal and cellular systems.

Metabolism’ may relate to lipids, bone and drug metabolism, or broader aspects of endocrine dysfunction.

Preclinical pharmacology, pharmacokinetic studies, meta-analyses and papers addressing drug safety and tolerability are also welcomed.

At Endocrinology, Diabetes & Metabolism, we aim to be a truly global forum for research, and we think that the best research should be published and made widely accessible as quickly as possible.

We advocate the principles of sound science publishing.

We only accept papers where the conclusions are substantiated by the data presented, while deemphasizing the importance of novelty.

If the science is reliable and sound, we will publish.

Endocrinology, Diabetes & Metabolism publishes original papers submitted directly to the journal and those referred from a select group of prestigious journals published by Wiley (list available here).

In order for research to advance, negative results, which often make a valuable contribution to the field, should be published.

However, articles containing negative or null results are frequently not considered for publication or rejected by journals.

We welcome papers of this kind, where appropriate and valid power calculations are included that give confidence that a negative result can be relied upon.

View Aims & Scope

Metrics & Ranking

Impact Factor

Year Value
2024 2.70

SJR (SCImago Journal Rank)

Year Value
2024 0.874

Quartile

Year Value
2024 Q2

h-index

Year Value
2024 22

Journal Rank

Year Value
2024 5956

Journal Citation Indicator

Year Value
2024 745

Impact Factor Trend


Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.


Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.


Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.


Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.


Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.


APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Medicine, ensuring accessibility and quality in research dissemination.

This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 3,120.00 USD. Learn more.

Explore journals without APCs for alternative publishing options.


Quick Facts

Current Factor
2.70
First Published: 2024

SJR (SCImago Journal Rank)

SJR
0.874
First Published: 2024

Quartile

Current Quartile
Q2
First Published: 2024

Similar Journals

Top Journals in Related Fields